Nektar Therapeutics Soared

Nektar Therapeutics (NKTR:NASDAQ) rocketted at $24.45, a gain of 156.3%. On Tue, Jun 24, 2025, NKTR:NASDAQ touched a New 2-Week High of $24.45. The stock appeared on our News Catalysts scanner on Tue, Jun 24, 2025 at 01:03 PM in the 'MISCELLANEOUS' category. From Tue, Jun 10, 2025, the stock recorded 33.33% Up Days and 60.00% Green Days
About Nektar Therapeutics (NKTR:NASDAQ)
Nektar Therapeutics Inc is a biopharmaceutical company engaged in the development of new molecules to treat diseases with unmet medical needs. The company's research and development activities involve small-molecule drugs, and peptides.
Top 10 Gainers:
- Nektar Therapeutics (NKTR:NASDAQ), 156.29%
- OneMedNet Corporation (ONMD:NASDAQ), 100.65%
- Youxin Technology Ltd (YAAS:NASDAQ), 95.45%
- Surf Air Mobility Inc. (SRFM:NYSE), 88.48%
- Eyenovia, Inc. (EYEN:NASDAQ), 64.6%
- Sound Group Inc. (SOGP:NASDAQ), 60.08%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 57.96%
- AIFU Inc. (AIFU:NASDAQ), 45.86%
- Nano Labs Ltd (NA:NASDAQ), 36.36%
- Rezolve AI PLC (RZLV:NASDAQ), 36.27%